Sanara MedTech (SMTI) Cash from Financing Activities (2016 - 2025)
Sanara MedTech's Cash from Financing Activities history spans 14 years, with the latest figure at $139427.0 for Q4 2025.
- For Q4 2025, Cash from Financing Activities rose 111.61% year-over-year to $139427.0; the TTM value through Dec 2025 reached $8.9 million, down 48.82%, while the annual FY2025 figure was $8.9 million, 48.82% down from the prior year.
- Cash from Financing Activities reached $139427.0 in Q4 2025 per SMTI's latest filing, up from -$774749.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $28.7 million in Q1 2021 to a low of -$2.5 million in Q2 2025.
- Average Cash from Financing Activities over 5 years is $3.7 million, with a median of -$102931.0 recorded in 2022.
- Peak YoY movement for Cash from Financing Activities: tumbled 3475.48% in 2021, then skyrocketed 1919.73% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at -$442525.0 in 2021, then skyrocketed by 31.21% to -$304415.0 in 2022, then surged by 38.94% to -$185888.0 in 2023, then tumbled by 546.06% to -$1.2 million in 2024, then surged by 111.61% to $139427.0 in 2025.
- Per Business Quant, the three most recent readings for SMTI's Cash from Financing Activities are $139427.0 (Q4 2025), -$774749.0 (Q3 2025), and -$2.5 million (Q2 2025).